Rezolute, Inc. current report, 29 June 2015

Full document

Business Context and Reporting Period

This Form 8-K is a current report filed by AntriaBio, Inc. (not Rezolute, Inc.) on June 29, 2015, covering events occurring on June 24, 2015. The filing primarily addresses corporate governance changes and regulatory disclosures.

Key Financial Metrics

This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The only financial figure disclosed relates to historical investment activity: LRFA, LLC, an entity in which the newly appointed director serves as president and beneficial owner, invested an aggregate of $3,200,000 in the Company through private placement financings between January 15, 2014, and April 6, 2015.

Material Changes

  • Board Appointment: On June 24, 2015, the Board of Directors appointed David F. Welch, Ph.D. as a new director.
  • Director Background: Dr. Welch is the President and co-founder of Infinera Corporation and previously held executive roles at SDL Inc.
  • Compensation: No agreement, arrangement, or understanding regarding compensation has been entered into with Dr. Welch for his board appointment.
  • Related Party Status: Dr. Welch is not related by blood or marriage to any current directors or executive officers.

Guidance, Outlook, and Risks

The filing contains no management guidance, financial outlook, or discussion of operational risks. It includes a Regulation FD disclosure stating that the press release announcing the appointment is "furnished" rather than "filed" and does not constitute an admission of materiality regarding the information contained therein.

Investor Verification Checklist

  • Verify the correct registrant name is AntriaBio, Inc. (the input metadata incorrectly listed Rezolute, Inc.).
  • Confirm the lack of compensation agreements for the new board member, Dr. Welch.
  • Note the significant historical investment ($3.2M) by an entity controlled by the new director.
  • Review the attached press release (Exhibit 99.1) for additional context on the appointment, as the 8-K text itself is limited.